Alimta & Off label use

8.3%

of users reported Off label use

56.5%

also reported Severe reaction

52.8%

are women

Severe reaction

56.5%

Hospitalization

26.6%

Death

11.0%

Life-threatening condition

4.9%

Disability

1.0%

Alimta: general information

20 - 29 years

0.3%

30 - 39 years

0.2%

40 - 49 years

6.1%

50 - 59 years

21.5%

60 - 69 years

39.1%

70 - 79 years

26.8%

80 - 89 years

5.9%